Altered neuronal chloride regulation may prolong sleep and autonomic disruption after awakening
In an ovarian-withdrawal model with verified thermal suppression by neurokinin 3 receptor blockade, altered chloride regulation may sustain stress-neuron output after awakening. Normal inhibitory polarity, or failure of verified polarity restoration to rescue recovery, would reject this mechanism
Stage of verification
- Hypothesis published2026-10-05
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Transporter
KCC2
A protein involved in neuronal chloride regulation and inhibitory signaling
Where this hypothesis actsHypothalamic stress-output neurons after repeated awakenings in an ovarian-withdrawal model
Hypotheses on this target 1
Inhibition
Lower level
Higher level
Blockade
Agonism
Function restoration1
What is proposed
Function restoration
Restore KCC2 function to normalize the chloride reversal potential
With whatNot stated in the record
HowCell-targeted KCC2 manipulation; the specific manipulation is not stated in the record
Possible result
Expected normalization of post-awakening cardiovascular recovery and sleep re-entry without restoring flashes
From the recordCell-targeted restoration of KCC2 function should normalize post-awakening cardiovascular recovery and sleep re-entry without restoring flashes.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Sleep and cardiovascular disturbances during menopause might persist even when hot flashes are controlled. The unexpected move is to propose that repeated awakenings change how certain brain cells respond to a normally restraining signal, allowing a signal that usually helps end stress to prolong it instead. This is a hypothesis generated by the pipeline, not a measured result.
- Repeated awakenings during the menopause transition are proposed to alter chloride control in hypothalamic stress-output neurons.
- Altered chloride control is proposed to switch GABA-A responses from effective restraint toward depolarization.
- With that switch, neurosteroid signaling is proposed to change from helping terminate stress to sustaining neuronal activity after awakening.
- Persistent neuronal activity is proposed to prolong cardiovascular disturbance and delay return to sleep.
- NK3 blockade, treatment that prevents signaling through neurokinin-3 receptors, is proposed to suppress flashes while leaving the chloride-dependent switch unchanged.
- Restoring chloride-dependent restraint is predicted to improve recovery after awakening, including an isolated awakening following a long uninterrupted recovery interval.
A building’s quiet-hours button normally turns activity down. The proposal resembles a wiring change that makes the same button keep activity going, even after a separate alarm has been silenced.
Where the picture breaks: The cells are not literally rewired, and an electrical shift toward depolarization does not by itself establish sustained activity. The proposed test must connect the changed response to continued neuronal output and impaired recovery.
- Master questionstep 01 of 04
Understanding the patterns of symptoms associated with menopause is intended to contribute knowledge toward radically extending lifespan.
Rests on: The goal treats menopause-associated disturbances as a possible source of knowledge about extending life.
AssumptionIt assumes that explaining these disturbances can inform radical lifespan extension; the supplied material establishes no connection between correcting them and extending lifespan.
- Goal pillarstep 02 of 04
Delayed responses during a transition are framed as a source of amplified disturbance that should be contained.
Rests on: The master question supplies the menopause context and the lifespan ambition, but does not identify delayed responses as the route connecting them.
LeapThe stage does not define the delayed response, explain how it amplifies disturbance, or supply the connection between containing that amplification and extending lifespan.
- Gap questionstep 03 of 04
Hot flashes may not be required to maintain disrupted sleep and automatic cardiovascular regulation if blocking neurokinin-3 receptors, cellular targets abbreviated NK3, removes objectively verified flashes while leaving responses to randomly scheduled awakenings unchanged.
Rests on: The preceding stage names delayed recovery as a concern; this stage gives it a concrete setting in recovery after awakening and proposes separating that recovery from hot flashes.
AssumptionIt takes recovery after awakening as an instance of the preceding stage’s undefined response delay. Flash suppression with unchanged awakening responses is a conditional scenario, not a reported result in the supplied material.
- Hypothesisstep 04 of 04
Repeated awakenings are proposed to change chloride regulation, the control of negatively charged chloride ions inside cells, in stress-output neurons of the hypothalamus, a brain region involved in coordinating bodily responses. This would shift gamma-aminobutyric acid type A receptor signaling, abbreviated GABA-A and normally restraining in the proposed starting state, toward depolarization, an electrical shift toward a less negative cell interior. Neurosteroids, steroids that alter nerve-cell signaling, would then sustain stress-related activity instead of helping terminate it.S5
Rests on: The preceding question supplies the possibility that recovery problems continue after flashes are suppressed. A related biological basis comes from S5, a 2014 review in Frontiers in Cellular Neuroscience, which reports reduced KCC2, potassium-chloride cotransporter 2, a protein that transports potassium and chloride across cell membranes, after acute restraint stress in a hypothalamic region. That report does not establish the proposed change after repeated awakenings or its effects on sleep and cardiovascular recovery.
Supported by literature
What is carried, and what is not. The screened literature supplies related support for stress-associated changes in chloride control and for drug treatment improving hot flashes and reported sleep disturbance; it does not establish the six-link mechanism above. In particular, S3, a 2025 review in Drugs, reports improved sleep disturbance with selective NK3 treatment, which challenges a blanket claim that sleep remains unchanged but does not measure recovery after imposed awakenings or establish restoration of neuronal restraint.S3
Where the reasoning is carried by something unstated · 3
- Master question. It assumes that explaining these disturbances can inform radical lifespan extension; the supplied material establishes no connection between correcting them and extending lifespan.
- Goal pillar. The stage does not define the delayed response, explain how it amplifies disturbance, or supply the connection between containing that amplification and extending lifespan. Establish the missing link before relying on this step.
- Gap question. It takes recovery after awakening as an instance of the preceding stage’s undefined response delay. Flash suppression with unchanged awakening responses is a conditional scenario, not a reported result in the supplied material.
How a result here could mislead · 3
- A change in the electrical response to GABA-A signaling could be mistaken for proof that neurosteroids now sustain stress-output activity. Conversely, a recording method that changes chloride inside the cell could obscure the very difference under investigation. What closes it: The proposed perforated-patch recording, an electrical recording method that better preserves the cell’s internal chloride than conventional whole-cell recording, must verify the GABA reversal potential, the voltage at which the net current driven by GABA-A activation changes direction. Establishing the proposed neurosteroid link additionally requires measuring whether neurosteroid signaling actually prolongs output in the affected neurons; that measurement is not specified.
- Failure of the KCC2 intervention could be read as rejection even if it never restored the intended electrical response. Improvement could also be credited to recovery after awakening when it instead reflects fewer thermal events or a different awakening burden. What closes it: Interpretation requires verified restoration of the electrical response in the intended cells, continued measurement of thermal suppression, and comparable awakening exposure across intervention and control conditions. The supplied prediction calls for verified restoration and independently verified thermal suppression, but does not specify all comparison conditions.
- Improved sleep and cardiovascular recovery could be treated as uniquely identifying the chloride mechanism even if the intervention changes a competing recovery process. The rivals attribute persistence to excessive blood-pressure feedback, repeated interruption of a recovery sequence, or a breathing-related fall in carbon dioxide. What closes it: The design must specify the recovery outcome and the long uninterrupted interval before testing. Distinguishing the rivals also requires measurements of blood pressure and heart rate together, breathing and carbon dioxide, and awakening timing; these combined measurements are not specified. The label SPV_4 has no supplied operational definition, so its stabilization cannot yet serve as a defined success criterion.
What would make this wrong. The hypothesis would be rejected if the targeted stress-output neurons retained normal inhibitory responses after the specified repeated awakenings, or if verified restoration of those responses failed to improve cardiovascular recovery and return to sleep under the stated flash-suppressed conditions. Failure of the predicted rescue for an isolated awakening after a long uninterrupted recovery interval would also contradict its distinguishing prediction.
What it would change. If the hypothesis held, persistent recovery problems in the tested model would have a causal explanation involving altered neuronal restraint that remains after hot flashes are suppressed. Work on menopause-associated disturbances would then need to distinguish control of flashes from restoration of recovery after awakening. The proposed ovarian-withdrawal model, an experimental system in which ovarian hormonal input is removed or reduced, would still not establish the same mechanism in humans, persistence after hormonal variability subsides, or any contribution to radical lifespan extension.
Sources read · 9
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. · JAMA · 2024
“Elinzanetant improved sleep disturbances and menopause-related quality of life at week 12, and the safety profile was favorable.”
Does not settle: The abstract establishes clinical improvement in vasomotor symptoms and self-reported sleep disturbance with combined NK1/NK3 antagonism in postmenopausal participants. It does not assess neuronal chloride regulation, GABA-A polarity, hypothalamic stress-output neurons, transition-associated arousals, neurosteroid signaling, isolated NK3 blockade, autonomic disruption after awakening, persistence after endocrine variability subsides, or restoration of the chloride reversal potential and SPV_4 stability.
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial. · JAMA internal medicine · 2025
“Elinzanetant also resulted in statistically significant improvements in sleep disturbances and menopause-related quality of life vs placebo at week 12.”
Does not settle: This source does not establish altered neuronal chloride regulation, transition-associated arousals, GABA-A depolarization, neurosteroid effects on hypothalamic stress-output neurons, restoration of chloride reversal potential, or persistence of autonomic and sleep disturbances after endocrine variability subsides. It studies dual NK-1/NK-3 blockade rather than isolated NK-3 blockade.
Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms. · Drugs · 2025
“Treatment with fezolinetant 45 mg sig-nificantly improved sleep disturbances (as measured by change from baseline in PROMIS-SD-SF 8b total score) at week 4 (SKLYLIGHT-1 p = 0.008; SKYLIGHT-2 > p < 0.001) and week 12 (SKYLIGHT-2 > p = 0.007) compared with treatment with placebo.”
Does not settle: The source does not establish whether NK3 blockade restores inhibitory chloride polarity, whether transition-associated arousals alter chloride regulation in hypothalamic stress-output neurons, whether GABA-A responses become depolarizing, whether neurosteroids sustain post-awakening neuronal output, or whether restoring the chloride reversal potential stabilizes SPV_4. It also does not establish persistence of autonomic or sleep disturbance after endocrine variability subsides.
Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis. · Obstetrics and gynecology · 2025
“Elinzanetant 120 mg showed a significant improvement in sleep quality (mean difference 4.65, 95% CI, 3.73-5.56, I2 =0%).”
Does not settle: The abstract does not establish neuronal chloride regulation, GABA-A polarity, hypothalamic stress-output neuron activity, neurosteroid signaling, post-awakening persistence, autonomic recovery, endocrine variability, or whether restoring the chloride reversal potential would stabilize SPV_4. It also does not report sleep outcomes for fezolinetant.
Stress-induced plasticity of GABAergic inhibition. · Frontiers in cellular neuroscience · 2014
“Following acute restraint stress, KCC2 is dephosphorylated at residue Ser 940 and downregulated in the PVN (Sarkar et al., ) (Table ).”
Does not settle: The source does not establish that transition-associated arousals cause this change, that GABA-A responses become depolarizing after awakening, that neurosteroids sustain post-awakening output, that NK3 blockade dissociates vasomotor events from sleep or autonomic disruption, or that restoring chloride reversal potential stabilizes SPV_4.
3alpha,5beta-Reduced cortisol exhibits antagonist properties on cerebral cortical GABA(A) receptors. · European journal of pharmacology · 2004
“3alpha,5beta-Reduced cortisol dose-dependently inhibited muscimol-stimulated chloride flux and tetrahydrodeoxycorticosterone potentiation of muscimol responses.”
Does not settle: The abstract does not establish altered chloride reversal potential or inhibitory polarity, effects in hypothalamic stress-output neurons, consequences of repeated arousals or awakening, persistence of sleep or autonomic disruption, NK3 blockade effects, or restoration of SPV_4.
Neuroactive steroids modulate GABA inhibition of hypothalamic somatostatin release. · Neuroreport · 1995
“These findings clearly establish that 3 alpha-hydroxysteroids modulate GABA inhibition of hypothalamic somatostatin release.”
Does not settle: The source does not establish altered chloride regulation or reversal potential, depolarizing GABA-A responses, effects of repeated arousals or awakening, persistence of sleep or autonomic disruption, hypothalamic stress-output neurons, NK3 blockade, vasomotor events, endocrine variability, or restoration of SPV_4.
Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. · Brain research · 1997
“The AP-, PROG- and 4'-CD-elicited anxiolytic behavior was blocked by picrotoxin (1 mg/kg), a GABA-A chloride channel antagonist, but not by flumazenil (2 mg/kg), a selective benzodiazepine (BZD) antagonist.”
Does not settle: This mouse anxiety-behavior study does not establish transition-associated arousals, hypothalamic stress-output neurons, altered chloride regulation or reversal potential, depolarizing GABA-A responses, post-awakening sleep or autonomic disruption, NK3 blockade, vasomotor events, persistence after endocrine variability subsides, or stabilization of SPV_4.
Differential regulation of K+-Cl- cotransporter 2 (KCC2) and Na+-K+-Cl- cotransporter 1 (NKCC1) expression by zolpidem in CA1 and CA3 hippocampal subregions of the lithium-pilocarpine status epilepticus rat model. · Experimental animals · 2025
“It is important to note that the role of GABAARs was not investigated in this study due to several significant limitations.”
Does not settle: The source does not establish effects of transition-associated arousals, awakening, sleep or autonomic disruption, hypothalamic stress-output neurons, neurosteroid signaling, NK3 blockade, vasomotor events, GABA-A response polarity, chloride reversal potential, or SPV_4. It studies KCC2 and NKCC1 protein expression after zolpidem treatment in hippocampal CA1 and CA3 regions of a pilocarpine-induced status epilepticus rat model.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
If blocking hot flashes leaves awakening responses unchanged, are flashes still necessary for lasting sleep and automatic body-control disruption?
Original wording · exactly as the pipeline generated it
If selective NK3 blockade suppresses objectively verified flashes but leaves responses to randomized awakenings unchanged, can vasomotor initiation still be the necessary driver of sustained sleep–autonomic instability?
What this question is asking
The question concerns whether hot flashes must start a lasting disturbance involving sleep and the body's automatic control of functions such as heart activity. It asks what follows if selectively blocking neurokinin 3 receptors, the drug targets named in the question, suppresses hot flashes confirmed by physiological measurements but leaves responses to deliberately induced awakenings unchanged. The comparison is whether those awakening responses persist with and without the blockade, including whether they return to their starting levels within recovery periods defined beforehand. The question assumes that suppressing measured flashes removes the initiating disturbance and that unchanged awakening responses could reveal a continuing cycle in which sleep disruption and bodily responses reinforce each other. Neither assumption is established by the supplied evidence.
- Menopause
- The life transition marking the end of menstrual cycles. It is the setting for the hot-flash and sleep question.
- Hot flashes; vasomotor symptoms
- Episodes of heat sensation and associated bodily changes described here as flashes. Vasomotor symptoms is the clinical category used for these symptoms; symptom reports and physiologically detected events are different measurements.
- Neurokinin B
- A signaling molecule discussed in S3 as part of pathways involved in hot flashes. Its involvement does not by itself establish the proposed continuing sleep disturbance.
- Neurokinin 3 receptor; NK3; NK3R
- A cellular receiver for chemical signals and the drug target named in the question. The abbreviations refer to neurokinin 3 or its receptor in this context.
- Neurokinin 1 receptor; NK1R
- Another cellular signal receiver included in the pathway discussed by S3. Evidence about a pathway involving several receptors does not isolate the effect of blocking neurokinin 3 alone.
- Selective blockade; antagonism
- An intervention intended to inhibit a particular receptor's signaling. Selectivity describes the target preference; it does not itself demonstrate complete elimination of flashes or their initiating action.
- Fezolinetant; elinzanetant
- The treatments named in the supplied clinical-source metadata. The supplied excerpts do not establish that their reported symptom or sleep outcomes answer the selective-blockade comparison.
- Objectively verified; physiologically confirmed
- Confirmed through measurements of bodily events rather than symptom reports alone. The supplied material does not specify the measurement method or its detection limits.
- Randomized awakenings
- Deliberately induced awakenings assigned according to a random procedure. The proposed procedure, including what is randomized and its comparison condition, is not specified.
- Arousal
- A shift toward wakefulness that may be briefer than a full awakening. The timing sources discuss both arousals and awakenings.
- Autonomic function; automatic body control
- Regulation of bodily functions without deliberate control, including aspects of heart activity. The question asks whether disturbances in this regulation persist alongside disturbed sleep.
- Sympathetic and parasympathetic activity
- Activity in two branches of automatic body control. S6 describes increased activity in the former and suppressed activity in the latter as consequences of the brain signaling it discusses.
- Locus coeruleus
- The brain region discussed in S6 as connecting changes in arousal with changes in automatic body control. That source addresses cancer-related sleep disruption.
- Sustained sleep–autonomic instability; amplification; feedback
- The proposed continuing disturbance in which sleep disruption and automatic bodily responses reinforce one another. These terms name the process being questioned, not a process demonstrated by the supplied sources.
- Prespecified recovery window
- A period defined before assessing results during which a response is expected to return toward its starting level. No duration is supplied here.
- Necessary driver; vasomotor initiation
- An initiating hot-flash-related event without which the specified disturbance cannot begin. A trigger can contribute to some episodes without being necessary for all episodes.
- Insomnia; cardiovascular responsiveness; acute psychosocial stress
- Insomnia means difficulty sleeping; cardiovascular responsiveness means changes in heart and blood-vessel function; acute psychosocial stress means a brief challenge involving psychological or social pressure. S8 examines their relationship, rather than the awakening comparison posed here.
- Evidence synthesis
- An analysis that brings together results from multiple studies. S2 combines treatment evidence for symptom outcomes, which does not supply the missing measurements of the proposed continuing disturbance.
Verified suppression of flashes by selective NK3 blockade removes vasomotor initiation, and unchanged responses to randomized awakenings demonstrate that the proposed amplification process remains intact.
The drug intervention blocks a named cellular receiver involved in hot-flash signaling, while physiological measurements would check whether flashes still occur. The assumption is that eliminating those measured events also eliminates the initiating signal, and that unchanged responses to deliberately induced awakenings reveal a lasting, self-reinforcing disturbance. Those links are needed to turn the proposed observations into a conclusion about whether flashes are necessary.
The supplied search results do not establish either link. S3 supports involvement of hot-flash signaling pathways, but does not show that selective blockade removes every relevant initiating event. S1 reports diary-based symptom measurement, and S2 reports symptom frequency and severity outcomes; neither supplies the objective verification or awakening-response measurements required here. S5 challenges a simpler assumption that flashes always precede awakenings, but does not establish an independent, lasting amplification process. These limitations do not show that the premise is false.S1S2S3S5
The same question asked without the part nothing read establishes:
- When selective neurokinin 3 receptor blockade reduces physiologically confirmed hot flashes, do responses to deliberately induced awakenings persist beyond predefined recovery periods?
- Does lasting disruption of sleep and automatic body control occur when no initiating hot flash is physiologically detected?
- Flashes are not necessary If the initiating action of flashes is genuinely absent and the same lasting disturbance still begins and persists, flashes cannot be necessary for that disturbance under those conditions. Symptom suppression would then leave the proposed continuing process possible.
- Flashes remain a possible necessary trigger If suppression leaves some initiating events intact, unchanged lasting responses could still follow those remaining events. The observation would therefore leave necessity unresolved, even if recorded flash frequency fell.
- Unchanged responses do not establish lasting instability If unchanged awakening responses subside within the predefined recovery periods, they do not demonstrate the persistent feedback specified by the question. Their preservation would therefore not disprove a necessary role for flashes in a separate, lasting disturbance.
The proposed causal chain starts with a hot flash, proceeds to disrupted sleep and changes in automatic body control, and ends with those disturbances reinforcing one another after the original flash ends. If flashes are required to start that chain, removing their initiating action should prevent it from starting. If lasting disruption continues without that action, suppressing flashes alone would not eliminate the process described in the question. However, reducing flashes does not by itself establish complete removal of their initiating action, and an unchanged immediate awakening response does not by itself establish lasting disruption. Treating either measurement as sufficient would confuse symptom relief with evidence about what causes the proposed continuing disturbance.
RL-3 NK3 antagonism suppresses symptoms; it has not demonstrated elimination of awakening-driven feedback or durable recovery.
Awakening-related autonomic and vasomotor responses decay within prespecified recovery windows, with no persistent feedback after the initiating disturbance ends.
Test whether verified removal of vasomotor initiation leaves the proposed amplification process intact, disproving its claimed necessity.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Repeated transition-associated arousals alter chloride regulation in hypothalamic stress-output neurons, shifting GABA-A responses from effective inhibition toward depolarization. Neurosteroid signaling that normally helps terminate stress then sustains neuronal output after awakening. NK3 blockade suppresses vasomotor events without restoring inhibitory polarity, allowing autonomic and sleep disturbances to persist after endocrine variability subsides. Restoring the chloride reversal potential would stabilize SPV_4.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
In an ovarian-withdrawal model with independently verified NK3-sensitive thermal suppression, stress-output neurons should exhibit a depolarized GABA reversal potential after repeated awakenings. Cell-targeted restoration of KCC2 function should normalize post-awakening cardiovascular recovery and sleep re-entry without restoring flashes. The rescue should persist for isolated awakenings after a long uninterrupted recovery interval. Normal inhibitory polarity, or failure of verified polarity restoration to rescue recovery, rejects this hypothesis.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable physiological outcomes, rescue effects, persistence conditions, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Perforated-patch recordings preserve intracellular chloride better than conventional whole-cell recording. Cell-targeted KCC2 manipulation and telemetry permit a preclinical causal test. Human EEG, cortisol or neurosteroid measurements cannot by themselves establish this mechanism.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
In an ovarian-withdrawal model with independently verified NK3-sensitive thermal suppression, stress-output neurons should exhibit a depolarized GABA reversal potential after repeated awakenings. Cell-targeted restoration of KCC2 function should normalize post-awakening cardiovascular recovery and sleep re-entry without restoring flashes. The rescue should persist for isolated awakenings after a long uninterrupted recovery interval. Normal inhibitory polarity, or failure of verified polarity restoration to rescue recovery, rejects this hypothesis.
- Rival 01 of 03What would separate them
Excessive heart-rate reflex correction may sustain instability after menopausal awakenings predicts: During verified flash suppression, isolated randomized awakenings produce alternating pressure and heart-period excursions whose persistence increases with experimentally estimated cardiovagal gain. In a mechanistic animal arm, partial, reversible attenuation of the cardiovagal reflex shortens cardiovascular settling time and sleep re-entry latency despite reducing vagal HRV; enhancing that reflex prolongs both. Compare at matched initial awakening intensity, mean pressure and ventilation. Absence of oscillatory overcorrection, or improvement with increased reflex gain, rejects this mechanism.
- Rival 02 of 03What would separate them
Repeated awakenings may restart the autonomic recovery sequence needed for sleep re-entry predicts: First estimate each participant's uninterrupted recovery duration, tau, from isolated awakenings during NK3 blockade. Then deliver matched second awakenings at different fractions of tau. Recovery completion should occur approximately tau after the last awakening, independent of progress before that awakening. A late interruption should erase more completed recovery than an early interruption. Once an uninterrupted interval exceeds tau, recovery should complete without a residual penalty from the earlier episode count. Preserved progress after interruption or persistent dysfunction after a sufficiently long quiet interval rejects the strict restart mechanism.
- What would separate them
Awakening-induced carbon dioxide loss may sustain breathing and autonomic instability predicts: During verified flash suppression, randomized awakenings should produce carbon-dioxide undershoot followed by hypoventilation and renewed autonomic activation. In a laboratory crossover, an individualized isocapnic gas clamp that prevents the undershoot should shorten cardiovascular recovery and sleep re-entry relative to sham gas delivery, with oxygen, apparatus effects and initial awakening intensity controlled. Recovery should remain abnormal under sham even when obstructive events are absent. Persistent instability despite successful prevention of carbon-dioxide excursions rejects the proposed sustaining loop.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.